AI assistant
Sending…
Iterum Therapeutics plc — Director's Dealing 2021
Dec 14, 2021
34796_dirs_2021-12-13_3c5f78bd-4a8a-418b-b917-d7df1cba2fad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2021-12-01
Reporting Person: Puttagunta Sailaja (Chief Medical Officer)
More from Iterum Therapeutics plc
Regulatory Filings
2026
Mar 31
Regulatory Filings
2026
Mar 27
Regulatory Filings
2026
Mar 3
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 18
Proxy Solicitation & Information Statement
2026
Jan 2
Regulatory Filings
2025
Dec 23
Regulatory Filings
2025
Dec 12
Director's Dealing
2025
Nov 20
Interim / Quarterly Report
2025
Nov 14